Reduced Expression Level of SHP1 Gives An Additive Survival Advantage to the Ph plus Cells of Chronic Myeloid Leukemia (CML) Patients and Provides a Novel Pretreatment Predictor of Major Molecular Response Achievement in CML Patients
| Autor: | Esposito, N, Quintarelli, C, Colavita, I, Izzo, B, Peluso, AL, Ruoppolo, M, Del Vecchio, L, Russo, D, Branford, S, Iacobucci, I, Thornquist, M, Barnett, M, Melo, J, Saglio, G, Radich, J, Peter, L, Martinelli, G, Kalebic, T, Hughes, T, Pane, F |
|---|---|
| Rok vydání: | 2010 |
| Zdroj: | (2010). info:cnr-pdr/source/autori:Esposito, N; Quintarelli, C; Colavita, I; Izzo, B; Peluso, AL; Ruoppolo, M; Del Vecchio, L; Russo, D; Branford, S; Iacobucci, I; Thornquist, M; Barnett, M; Melo, J; Saglio, G; Radich, J; Peter, L; Martinelli, G; Kalebic, T; Hughes, T; Pane, F/titolo:Reduced Expression Level of SHP1 Gives An Additive Survival Advantage to the Ph plus Cells of Chronic Myeloid Leukemia (CML) Patients and Provides a Novel Pretreatment Predictor of Major Molecular Response Achievement in CML Patients/doi:/rivista:/anno:2010/pagina_da:/pagina_a:/intervallo_pagine:/volume |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|